DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Islatravir
Islatravir
Enfermedades Infecciosas Y Microbiología Clínica Enfermedades Infecciosas Y
Merck & Co., Inc
(51) International Patent Classification: Declarations Under Rule 4.17
What's New in Hiv? Highlights & New Data on Hiv Treatment a Presentation for Healthtrust Members June 18, 2021
To View the CAHR 2020 Abstract Book
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescent Living With
Prep and Microbicides PIPELINE REPORT 2021
Merck Announces Week 96 Data from Phase 2B Study Evaluating Islatravir in Combination with Doravirine in Adults with HIV-1 Infection
Antiretroviral Drugs Impact Autophagy with Toxic Outcomes
Prioritisation of Hiv, Hepatitis C and Tuberculosis Medicines for In-Licensing by the Medicines Patent Pool - 2019 Table of Contents
Download the Article On
Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/Stis and Unplanned Pregnancy
Inhibitors & Agonists Compound Screening Libraries
PATHOLOGY of HIV/AIDS 32Nd Edition
Repurposing of FDA Approved Drugs
Merck & Co., Inc
Novel Antiretroviral Agents
Overview of Antiretrovirals for HIV Treatment
Top View
Management of the Treatment-Experienced Patient
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Islatravir Selects for HIV-1 Variants in MT4-GFP Cells That Profoundly
J. Boyd Francis, M.D. Lectureship HIV Primary Care: an Update on Management and Prevention
Hiv 2020/2021
Evolving Access Pathways for Long-Acting HIV Prevention Products
Centers for Disease Control and Prevention National Center for HIV
Draft-Hiv-Bnab-Ppc-Public-Comment
24 July 2019: No 9 IAS 2019: First Reports
HIV Treatment Bulletin (HTB) Every Two Months by E-Mail
Bioactive Compound Library Plus (96-Well)
Missing Data, Missing Diversity: Participant Demographics in Industry- Sponored Hiv Studies, 2010- 2020
By WT and Nucleoside Reverse Transcriptase Inhibitor Resistant
Update on Long-Acting Arvs
Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase
HIV Disease Narrative 2019
(2006.01) C07d 413/14
Safety, Pharmacokinetics, and Antiretroviral Activity of Islatravir
Structural Features in Common of HBV and HIV-1 Resistance Against
An Overview of Human Immunodeficiency Virus-1 Antiretroviral Drugs: General Principles and Current Status
Drug Repurposing Compound Library Plus (96-Well)
Human Immunodeficiency Virus
COVID User's Guide (Updated: 14/12/2020)
Merck Announces Presentation of New Data from Broad HIV Program at IAS 2021
Mercer University Clinical Research Department Is Proud to Offer a Large Number of Clinical Trials for Patients and Potential Patients
Drug Repurposing Compound Library (96-Well)
December 4-7, 2019 • New Orleans, LA Hyatt Regency New Orleans
Deanne Jackson Rudd; Youfang Cao; Pavan Vaddady; Jay A. Grobler; Ernest Asante-Appiah; Tracy Diamond; Stephanie Klopfer; Anjana